![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BIOPHAN RESTRUCTURES BOARD IN CONNECTION WITH APPLICATION FOR LISTING ON NATIONAL EXCHANGE
BIOPHAN RESTRUCTURES BOARD IN CONNECTION WITH APPLICATION FOR LISTING ON NATIONAL EXCHANGE
June 15, 2006
Biophan Technologies, Inc., a developer of next-generation medical technology, today announced that it is reducing the size of its board of directors from 7 to 5 members in order to have a majority of independent directors to satisfy one of the qualifications for listing on a major national stock exchange. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2554236)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct